Technology
Health
Biotechnology

Microbot Medical

$7.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.61%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MBOT and other stocks, options, ETFs, and crypto commission-free!

About

Microbot Medical Inc. Common Stock, also called Microbot Medical, is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Read More The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Employees
10
Headquarters
Hingham, Massachusetts
Founded
1988
Market Cap
22.14M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
615.88K
High Today
$7.61
Low Today
$7.23
Open Price
$7.61
Volume
9.91K
52 Week High
$19.40
52 Week Low
$0.5204

Collections

Technology
Health
Biotechnology
Medical
US
North America

News

Associated PressApr 23

Microbot Medical Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System

HINGHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian Intellectual Property Office for Patent Application No. 2,850,279, which pertains to a device for the prevention of shunt stenosis. With this latest Notice of Allowance, the Company now has 32 issued/allowed patents and 19 patent applications pending worl...

470

Earnings

Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available May 15, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.